{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:46:00Z","timestamp":1790721960312,"version":"4.1.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,9,3]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>SRL and PDN often induce disease stabilization or objective responses in patients with ECD. The phosphorylated forms of mTOR and of its downstream kinase p70S6K are strongly expressed in infiltrating histiocytes.<\/jats:p>","DOI":"10.1182\/blood-2015-01-620377","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T07:37:50Z","timestamp":1433403470000},"page":"1163-1171","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":84,"title":["Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial"],"prefix":"10.1182","volume":"126","author":[{"given":"Davide","family":"Gianfreda","sequence":"first","affiliation":[{"name":"Nephrology Unit, Department of Emergency and Clinical Medicine, University Hospital, Parma, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nicastro","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Emergency and Clinical Medicine, University Hospital, Parma, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricla","family":"Galetti","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Emergency and Clinical Medicine, University Hospital, Parma, Italy;"},{"name":"Italian Workers\u2019 Compensation Authority Research Center, Department of Clinical and Experimental Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Alberici","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Emergency and Clinical Medicine, University Hospital, Parma, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Corradi","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Biotechnological and Translational Sciences, Unit of Pathology, University of Parma, Parma, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Becchi","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Biotechnological and Translational Sciences, Unit of Pathology, University of Parma, Parma, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Baldari","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"De Filippo","sequence":"additional","affiliation":[{"name":"Radiology Service, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Ferretti","sequence":"additional","affiliation":[{"name":"Urology Unit, University Hospital, Parma, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Policlinico Hospital, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Foti","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University Hospital Policlinico Vittorio Emanuele, Catania, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Di Gangi","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University Hospital Policlinico Vittorio Emanuele, Catania, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Jeannin","sequence":"additional","affiliation":[{"name":"Nephrology Unit, University Hospital, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Saffroy","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology Department, Paul Brousse Hospital, APHP, Villejuif, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Emile","sequence":"additional","affiliation":[{"name":"EA4340 and Pathology Department, Versailles University and Ambroise Par\u00e9 Hospital, Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Buzio","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Emergency and Clinical Medicine, University Hospital, Parma, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[{"name":"Nephrology Unit, Department of Emergency and Clinical Medicine, University Hospital, Parma, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111705462770200_B1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/BOR.0b013e32834d861d","article-title":"Erdheim-Chester disease.","volume":"24","author":"Haroche","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"2019111705462770200_B2","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","article-title":"CNS involvement and treatment with interferon-\u03b1 are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients.","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111705462770200_B3","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/art.22165","article-title":"Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients.","volume":"54","author":"Haroche","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2019111705462770200_B4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/modpathol.3880583","article-title":"Erdheim-Chester disease: case report, PCR-based analysis of clonality, and review of literature.","volume":"15","author":"Al-Quran","year":"2002","journal-title":"Mod Pathol"},{"issue":"9","key":"2019111705462770200_B5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0046-8177(99)90228-9","article-title":"Chester-Erdheim disease: a neoplastic disorder.","volume":"30","author":"Chetritt","year":"1999","journal-title":"Hum Pathol"},{"issue":"13","key":"2019111705462770200_B6","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111705462770200_B7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2013-02-482984","article-title":"Detection of an NRAS mutation in Erdheim-Chester disease.","volume":"122","author":"Diamond","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2019111705462770200_B8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/his.12443","article-title":"An NRAS mutation in a case of Erdheim-Chester disease.","volume":"66","author":"Aitken","year":"2015","journal-title":"Histopathology"},{"issue":"6","key":"2019111705462770200_B9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/rheumatology\/kep461","article-title":"Erdheim-Chester disease: report on a case and new insights on its immunopathogenesis.","volume":"49","author":"Dagna","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"2019111705462770200_B10","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1002\/art.22280","article-title":"Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis.","volume":"54","author":"Stoppacciaro","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2019111705462770200_B11","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2010-10-313510","article-title":"Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients.","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111705462770200_B12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2019111705462770200_B13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.","volume":"33","author":"Haroche","year":"2015","journal-title":"J Clin Oncol"},{"issue":"19","key":"2019111705462770200_B14","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease.","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2019111705462770200_B15","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1182\/blood-2008-03-148304","article-title":"Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis.","volume":"111","author":"Haroche","year":"2008","journal-title":"Blood"},{"issue":"20","key":"2019111705462770200_B16","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2010-04-279240","article-title":"Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease.","volume":"116","author":"Aouba","year":"2010","journal-title":"Blood"},{"issue":"28","key":"2019111705462770200_B17","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1200\/JCO.2012.41.9911","article-title":"Tumor necrosis factor \u03b1 as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab.","volume":"30","author":"Dagna","year":"2012","journal-title":"J Clin Oncol"},{"key":"2019111705462770200_B18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of immune responses by mTOR.","volume":"30","author":"Powell","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"2019111705462770200_B19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1517\/14656566.2013.791677","article-title":"Evaluation of everolimus in renal cell cancer.","volume":"14","author":"Amato","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"2019111705462770200_B20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/1744666X.2014.872562","article-title":"The pros and the cons of mTOR inhibitors in kidney transplantation.","volume":"10","author":"Ponticelli","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"2019111705462770200_B21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","article-title":"Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases.","volume":"75","author":"Veyssier-Belot","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"2019111705462770200_B22","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis.","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111705462770200_B23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"9788","key":"2019111705462770200_B24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","article-title":"Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial.","volume":"378","author":"Vaglio","year":"2011","journal-title":"Lancet"},{"issue":"suppl 1","key":"2019111705462770200_B25","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors.","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"2019111705462770200_B26","unstructured":"US Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE). Available at: http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed November 16, 2014"},{"issue":"4","key":"2019111705462770200_B27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"issue":"14","key":"2019111705462770200_B28","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1161\/CIRCULATIONAHA.108.767467","article-title":"Pericarditis heralding Erdheim-Chester disease.","volume":"118","author":"Vaglio","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"2019111705462770200_B29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.semarthrit.2011.11.004","article-title":"Treatment of Erdheim-Chester disease with long-term high-dose interferon-\u03b1.","volume":"41","author":"Hervier","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"14","key":"2019111705462770200_B30","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/WNL.0000000000000832","article-title":"Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease.","volume":"83","author":"Cohen-Aubart","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"2019111705462770200_B31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.md.0000145368.17934.91","article-title":"Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review.","volume":"83","author":"Haroche","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"2019111705462770200_B32","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease.","volume":"23","author":"Hers","year":"2011","journal-title":"Cell Signal"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/10\/1163\/1388407\/1163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/10\/1163\/1388407\/1163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T05:46:42Z","timestamp":1573969602000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/10\/1163\/73114\/Sirolimus-plus-prednisone-for-ErdheimChester"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,9,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-01-620377","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}